Prevent Cancer Advocacy Workshop explores cancer screening disparities in the LGBTQ+ community | Your money
Alexandria, Va., May 10, 2022 (GLOBE NEWSWIRE) — The Prevent Cancer Foundation® will host its annual Advocacy Workshop virtually on Thursday, March 19. The workshop will explore cancer screening disparities in the LGBTQ+ community, convening patient advocacy organizations and LGBTQ+ community and healthcare experts to discuss the unique barriers the LGBTQ+ community faces when access to the health care system.
A recent survey by the Prevent Cancer Foundation found that 47% of LGBTQ+ people say their LGBTQ+ status has not been disclosed to their healthcare provider. According to the American Cancer Society, regardless of their sexual orientation, people whose health care providers knew their sexual orientation were more likely to have been encouraged to get screened for cancer than people whose providers did not know. not their sexual orientation.
The Prevent Cancer Foundation and its peer advocacy organizations aim to change that by addressing the lack of data on sexual orientation and gender identity and researching LGBTQ+ people’s experiences with their healthcare providers to better understand and overcome barriers to cancer screening.
The advocacy workshop will feature the following speakers:
Jody Hoyos, President and COO, Prevent Cancer FoundationScout, Ph.D., Executive Director, National LGBT Cancer NetworkChris Chamars, Programs and Partnerships Specialist, GRYT HealthChristina N. Dragon, MSPH, CHES, Head of Metrics and Data for Sexual Relationships and Office of Gender Minority Research, National Institute of HealthMandi L. Pratt-Chapman, Ph.D., Associate Professor, Medicine, School of Medicine and Health Sciences, Associate Professor, Prevention and Community Health, Milken Institute School of Public Health, Associate Center Director, Patient-Centered Initiatives and Health Equity, GW Cancer Center, The George Washington University Ari Laoch, LPC, CRC, CBIST, Health Brigade Rachel Waller, MD, Health BrigadeJordin Cotman, Health Brigade
Each year, the Foundation’s Advocacy Workshop serves as a forum for patients, providers, advocacy organizations and other partners to discuss pressing issues that impact cancer prevention and early detection and assess whether there are opportunities or needs for legislative action as well as gaps in education. and research.
“LGBTQ+ people experience differential and inequitable treatment in all areas of life, including health and access to healthcare services. The lack of data on the needs and experiences of LGBTQ+ people is a barrier, but the cancer prevention workshop will help us better determine what needs to change to reduce disparities in cancer risk, screening and treatment said Caitlin Kubler, Policy Director. and advocacy at the Prevent Cancer Foundation.
The event is free and open to all. Register here.
Prevent Cancer Foundation
2022 Prevent Cancer Advocacy Workshop: Cancer Screening Disparities in the LGBTQ+ Community
Thursday, May 19 at 1 p.m. ET
Virtual (You will receive a link when you register)
About the Cancer Prevention Foundation®
The Prevent Cancer Foundation® celebrates 35 years as America’s only nonprofit organization focused solely on saving lives in all populations through the prevention and early detection of cancer. Through research, education, awareness and advocacy, we have helped countless people avoid a cancer diagnosis or catch their cancer early enough to be treated successfully.
The Foundation is mobilizing to meet the challenge of reducing cancer deaths by 40% by 2035. To achieve this, we are committed to investing $20 million in innovative technologies to detect cancer early and advance multi-cancer screening , $10 million to expand cancer screening and vaccination access to medically underserved communities and $10 million to educate the public about screening and vaccination options. For more information, please visit www.preventcancer.org.
Kyra Meister Prevent Cancer Foundation 703-836-1746 [email protected]
Copyright 2022 GlobeNewswire, Inc.